Drug intelligence / Profile preview

technetium Tc 99m-labeled tin colloid

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Technetium Tc 99m-labeled tin colloid is a radiopharmaceutical used primarily for the in vitro labeling of leukocytes (white blood cells) to assist in the diagnosis of infection and inflammation. The preparation involves reducing pertechnetate (TcO4-) with stannous ion (Sn2+), resulting in a tin-based technetium-99m labeled particulate that can be phagocytosed by leukocytes. After labeling, these cells are re-injected into the patient and imaged using gamma cameras to localize sites of active infection or inflammation due to their migration and accumulation at such sites. This technique has been used clinically for over two decades[5][7][6].

Other names
technetium-99m tin colloidtechnetium99m tin colloidtechnetium 99m tin colloidtechnetium-99m-tin fluoride colloidtechnetium99m-tin fluoride colloidtechnetium 99m-tin fluoride colloidTc-99m-tin fluoride colloidTc99m-tin fluoride colloidTc 99m-tin fluoride colloid

Beyond the preview

Go deeper on technetium Tc 99m-labeled tin colloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium Tc 99m-labeled tin colloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call